Cas:20168-99-4 cinmetacin manufacturer & supplier

Chemical Name:cinmetacin

CAS.NO:20168-99-4

Synonyms:5-Methoxy-2-methyl-1-(1-oxo-3-phenyl-2-propenyl)-1H-indole-3-acetic acid;1-cinnamoyl-5-methoxy-2-methyl-1-indole-3-acetic acid;1-Cinnamoyl-5-methoxy-2-methyl-indol-3-yl-essigsaeure;Cindomet;(1-Cinnamoyl-5-methoxy-2-methyl-3-indolyl)-essigsaeure;cinmethacin;[5-methoxy-2-methyl-1-(3-phenyl-acryloyl)-indol-3-yl]-acetic acid;Indolacin;1-(1-Oxo-3-phenyl-2-propenyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid

Molecular Formula:C₂₁H₁₉NO₄

Molecular Weight:349.38000

HS Code:2933990090

Physical and Chemical Properties:

Melting point:170-172°; mp 164-165°

Boiling point:488ºC at 760mmHg

Density:1.19g/cm3

Index of Refraction:1.593

PSA:68.53000

Exact Mass:349.13100

LogP:3.93900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Methoxy-2-methyl-1-(1-oxo-3-phenyl-2-propenyl)-1H-indole-3-acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(1-Oxo-3-phenyl-2-propenyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Indolacin Use and application,5-Methoxy-2-methyl-1-(1-oxo-3-phenyl-2-propenyl)-1H-indole-3-acetic acid technical grade,usp/ep/jp grade.

Related News: The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. cinmetacin manufacturer The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs. cinmetacin supplier Secretary of Health Francisco Duque said authorities are working with the Chinese embassy to respectfully handle the remains of the man while following international protocol to contain the disease. cinmetacin vendor CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch. cinmetacin factory The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.